TYRA Biosciences Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
TYRA Biosciences Inc
TickerTYRA
CIK #0001863127
CUSIP90240B106
SectorLife Sciences - Pharmaceutical Preparations
Address2656 State Street, Carlsbad, CA 92008
Source [EDGAR]
CIK Filing 2011 - 2024
[0001863127] 10-K
[0001863127] 10-Q
[0001863127] 3
[0001863127] 4
[0001863127] 8-K
[0001863127] SC 13D
[0001863127] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Biotechnology Value Fund L P TYRA Biosciences Inc [2022-03-24] 3.2
FMR LLC TYRA Biosciences Inc [2022-02-09] 0.0
Canaan Xi LP TYRA Biosciences Inc [2022-02-08] 9.5
RA Capital Management LP TYRA Biosciences Inc [2021-09-27] 17.0
Nextech VI Oncology SCSP TYRA Biosciences Inc [2021-09-27] 5.9
Alta Partners Nextgen Fund II Management LLC TYRA Biosciences Inc [2021-09-27] 0.6
Boxer Capital LLC TYRA Biosciences Inc [2021-09-24] 14.9
TCG Crossover Management LLC TYRA Biosciences Inc [2021-09-21] 8.7
Form 3/4/5 Filer 2011 - 2024
Kaplan Gilla
Tyra Biosciences, Inc.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund, L.P.
RA Capital Management LP
Shah Rajeev M.
Kolchinsky Peter
Verjee Rehan
Simson Jake
Subramony Siddarth
More Robert J
Kjellson Nina S
Chen ISAN
Harris Todd
Bensen Daniel
Tada Hiroomi
Patel Piyush R.
Davis Aaron I.
MVA Investors, LLC
Fuhrman Alan
van den Boom Esther
Hudkins Robert L.
Swanson Ronald V.
Fawaz Ali D.
Healy John Stephen
Boxer Capital, LLC
Boxer Asset Management Inc.
Lewis Joseph
Chen Bihua
Cormorant Private Healthcare Fund III LP
Cormorant Global Healthcare Master Fund, LP
Cormorant Asset Management, LP
Canaan 2020+ Co-Investment L.P. Series 7
Canaan Partners 2020+ Co-Investment LLC
Canaan XI L.P.
Canaan Partners XI LLC
Alta Partners NextGen Fund II Management, LLC
Hudson Peter A
Alta Partners NextGen Fund II, L.P.
Janney Daniel
McCracken Melissa
Form 13F Holdings
Firm Period DFND Voting Shares
RA Capital Management LP [2023-03-31] SOLE 0.0 7,236,454.0
Boxer Capital, LLC [2023-03-31] OTR 6,448,359.0 6,448,359.0
Canaan Partners XI LLC [2023-03-31] SOLE 4,409,991.0 4,409,991.0
BVF Inc/IL [2023-03-31] DFND 0.0 3,239,595.0
FMR LLC [2023-03-31] DFND 3,147,781.0 3,147,987.0
Nextech Invest Ltd [2023-03-31] SOLE 2,518,582.0 2,518,582.0
TCG Crossover Management LLC [2023-03-31] SOLE 1,989,103.0 1,989,103.0
Frazier Life Sciences Management LP [2023-03-31] SOLE 1,421,310.0 1,421,310.0
Fairmount Funds Management LLC [2023-03-31] SOLE 1,416,998.0 1,416,998.0
BlackRock Inc. [2023-03-31] SOLE 648,316.0 666,885.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 628,453.0
Perceptive Advisors LLC [2023-03-31] SOLE 494,403.0 494,403.0
Woodline Partners LP [2023-03-31] SOLE 410,435.0 410,435.0
Geode Capital Management LLC [2023-03-31] DFND 286,104.0 286,104.0
State Street Corp [2023-03-31] DFND 217,389.0 232,089.0
JPMorgan Chase & Co [2023-03-31] DFND 167,716.0 192,509.0
Driehaus Capital Management LLC [2023-03-31] SOLE 134,173.0 134,173.0
Northern Trust Corp [2023-03-31] DFND 575.0 107,542.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 102,370.0 102,370.0
Logos Global Management LP [2023-03-31] SOLE 87,673.0 87,673.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 84,260.0
Bank of America Corp /DE/ [2023-03-31] DFND 1,910.0 58,011.0
Ikarian Capital LLC [2023-03-31] SOLE 48,170.0 48,170.0
Artia Global Partners LP [2023-03-31] SOLE 45,253.0 45,253.0
Bank of New York Mellon Corp [2023-03-31] DFND 35,917.0 41,531.0
Victory Capital Management Inc [2023-03-31] SOLE 33,760.0 33,760.0
Fishman Jay A Ltd/Mi [2023-03-31] SOLE 0.0 22,000.0
RhumbLine Advisers [2023-03-31] SOLE 8,952.0 21,926.0
Mariner LLC [2023-03-31] SOLE 180.0 21,529.0
LPL Financial LLC [2023-03-31] SOLE 0.0 19,500.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com